DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Aristo Bio-Tech And Lifescience Limited — Certificate under SEBI (Depositories and Participants) Regulations, 2018

NSE 53 min ago·7 Oct 2026, 9:04 am

Aristo BIO T AND Lifesc L

Aristo Bio-Tech And Lifescience Limited has informed the stock exchanges that it has received its Certificate of Compliance for the quarter ended September 30, 2026. This document confirms that the company has adhered to the SEBI (Depositories and Participants) Regulations, 2018, specifically regarding the maintenance of its dematerialized securities accounts. The filing is a routine regulatory requirement for listed entities.

For investors, this news is largely procedural and carries no immediate financial implications. It serves as an official confirmation that the company's shareholding structure and depository operations are in order. While this does not indicate any new business developments, it helps maintain the company's compliance record with market regulators.

Moving forward, investors should monitor the company's regular quarterly earnings reports and operational updates. This compliance certificate is a standard administrative update and does not alter the fundamental outlook of the stock. Continued focus should remain on the company's core business performance and growth trajectory.